Trending Now
Xeris Pharmaceuticals, Inc. (NASDAQ: XERS) Signs an Exclusive License and Supply...
Estimates have it that more than five million patients live on insulin and are at risk of severe hypoglycemia. The bad news is that...
Bio-Path Holdings (NASDAQ: BPTH) announces the successful completion of the second...
Bio-Path Holdings, Inc. (NASDAQ: BPTH), a pioneer in biotechnology, has recently achieved a critical milestone in its fight against acute myeloid leukemia...
Wall Street Bulls Eye a 290% Upside on Actinium Pharmaceuticals, Inc....
Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM), a trailblazer in the development of Antibody Radiation Conjugates (ARCs) and targeted radiotherapy treatments, is at...
Popular News
The FDA Agrees With Aldeyra Therapeutics Inc. (NASDAQ:ALDX) On RASP Inhibitor...
Aldeyra Therapeutics Inc. (NASDAQ:ALDX) has announced that it has reached an agreement with the FDA regarding the uses of reactive aldehyde species (RASP) as...
MAKE IT MODERN
LATEST REVIEWS
Incyte (NASDAQ:INCY) Enters Agreement With Nimble Therapeutics For the discovery of...
Incyte (NASDAQ:INCY) has entered a strategic collaboration with Nimble Therapeutics Inc. for the discovery of first in class peptide therapies in different disease areas.
Nimble...
MAKE IT MODERN
PERFORMANCE TRAINING
Adptimmune Therapeutics Plc (NASDAQ: ADAP) Releases Encouraging Data From SURPASS Study in Multiple Tumors
Adptimmune Therapeutics Plc (NASDAQ: ADAP) has announced its latest data from the first phase SURPASS study in multiple solid tumors. The data will be...
Sorrento Therapeutics Inc. (NASDAQ: SRNE) Receives Approval From ANVISA To Commence Phase 2A Study...
Sorrento Therapeutics Inc. (NASDAQ: SRNE) has received approval from the Brazilian Regulatory Agency (ANVISA) to go on with the Phase 2A placebo-controlled, randomized trial...
AC Immune SA (NASDAQ: ACIU) Hosted a Webinar About a-synuclein
AC Immune SA (NASDAQ: ACIU) hosted Dr. Oscar Hansson, a top research scientist, on a webinar about a-synuclein. This is a therapeutic target to...
Compugen Ltd. (NASDAQ: CGEN) Will Give Presentation at the Keystone Symposium on Cancer Immunotherapy
Compugen Ltd. (NASDAQ: CGEN) announced it would be giving a presentation at the Keystone Symposium on existing the immune tumor microenvironment through...
Titan Pharmaceuticals Inc. (NASDAQ:TTNP) Releases Q1 2020 Results And Updates of Its Expansion Of...
Titan Pharmaceuticals Inc. (NASDAQ:TTNP) has announced its Q1 2020 financial results and provided operational updates.
Titan Pharmaceuticals reports revenue of $1.3 million in Q1
The company...
MAKE IT MODERN
POPULAR
